National Bank of Canada’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
National Bank of Canada's BMY Position: Q2 2026 in Review
National Bank of Canada increased its Bristol-Myers Squibb (BMY) stake by 9.3% in Q2 2026, buying an estimated $12.6M and bringing the position to 2,580,079 shares worth $149M. The position accounts for 0.11% of the portfolio, ranked #162.
National Bank of Canada first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $166M in Q4 2025. 1,743 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- National Bank of Canada held 2,580,079 shares of Bristol-Myers Squibb worth $149M as of Q2 2026.
- National Bank of Canada bought 219,777 Bristol-Myers Squibb shares in Q2 2026, an estimated $12.6M.
- Bristol-Myers Squibb made up 0.11% of National Bank of Canada's portfolio in Q2 2026, its #162 holding.
- National Bank of Canada first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- National Bank of Canada's Bristol-Myers Squibb position peaked at $166M in Q4 2025.
- 1,743 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.